Illuminare Biotechnologies

Funding and NIH signals

• SEC Form D raise Raised $3.65M (Form D filed Jun 4, 2026). SEC Form D 0001701523-26-000003 (Jun 4, 2026)
  Evidence (1 event)

  • Jun 4, 2026 · SEC Form D 0001701523-26-000003
    Name of Issuer: Illuminare Biotechnologies Inc; CIK: 1701523; Address: Brooklyn, NY; Submission type: D; Filing date: 2026-06-04; Industry Group: Biotechnology; Date of First Sale: 2026-05-07; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 3650000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals